Skip to content
Therapy But Better – Lifestyle
Author:
Slate Medicines
Slate Medicines Announces First Participant Dosed in Phase 1 Study Evaluating SLTE-1009
August 27, 2026
Slate Medicines Establishes Clinical and Scientific Advisory Boards to Advance Next-Generation Migraine Prevention Therapeutics
July 28, 2026
Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn
July 15, 2026